GET DAILY SIGNALSWhy Is AirSculpt Technologies (AIRS) Stock Down 54.53% Today?
Key Takeaways
- AIRS shares plunged roughly 54% intraday to about $0.65, down from a prior close of $1.44.
- The primary catalyst was a third-quarter earnings miss, with revenue and EPS both coming in below analyst expectations.
- Management slashed full-year 2026 guidance, signaling that weak demand is expected to persist through the fourth quarter.
- The sell-off diverged sharply from a rising broader market, underscoring a company-specific rather than macro-driven decline.
- Investors are watching for signs of stabilization in procedure volumes and the company's GLP-1 growth strategy.
- For more detail on Price Targets, Earnings, and Forecast, explore AIRS's dedicated analysis pages.
- Discover how AI-driven trading strategies are navigating today's market on the Trending AI Robots page.
Opening Summary
AirSculpt Technologies, Inc. (AIRS), a provider of premium, minimally invasive body contouring procedures, saw its stock crater in Friday's session after reporting disappointing third-quarter results and reducing its full-year outlook. Shares tumbled about 54% to roughly $0.65, compared with a prior session close of $1.44. The move was driven almost entirely by a fundamental earnings miss: revenue fell short of estimates, same-store procedure volumes declined, and management lowered its guidance, prompting investors to reprice the stock aggressively.
Earnings Miss and Softening Demand
The immediate trigger was the company's third-quarter fiscal 2026 report. Revenue declined 8.7% year over year to $31.9 million, missing the consensus estimate of roughly $34.5 million. Adjusted earnings per share came in at a loss of $0.10, well below the approximately $0.02 loss analysts had projected. Adjusted EBITDA collapsed to about $0.4 million from $3.0 million a year earlier, reflecting both lower revenue and reduced operating leverage.
Underlying the shortfall was a 9.6% decline in same-center procedure volume, as fewer patients opted for the company's premium body sculpting treatments. Management also noted that higher customer acquisition costs—partly tied to changes in AI-generated search results affecting web traffic—weighed on marketing efficiency. These demand-side pressures, rather than a one-time accounting item, explain the severity of the market reaction.
Guidance Cut Weighs on Sentiment
Compounding the earnings miss, AIRS lowered its full-year 2026 outlook. The company now expects revenue of $144 million to $146 million, down from its prior forecast of $151 million to $157 million, and adjusted EBITDA of $9 million to $10 million, down from $12 million to $14 million. Management said the revised range assumes that the weakness seen in the third quarter continues into the fourth quarter.
Guidance cuts typically amplify post-earnings sell-offs because they signal that the issues are not yet resolved. In this case, the lowered outlook reinforced investor concerns about the durability of demand for elective aesthetic procedures in a challenging consumer spending environment.
Balance Sheet Moves and Refinancing
In a separate disclosure, the company completed a refinancing of its existing term loan with a new $44 million facility, including a $39 million term loan and a $5 million revolving credit line maturing in 2031. The company ended the quarter with about $15 million in cash and roughly $20 million in total liquidity. While the refinancing provides longer-term financial flexibility, it did little to offset the negative read-through from weak operating results and was overshadowed by the guidance reduction.
Market Context and Trading Activity
The decline in AIRS stood in stark contrast to the broader tape, with major indices trading higher on the session and the Nasdaq posting strong gains following better-than-expected October nonfarm payrolls. This divergence confirms the move was driven by company-specific fundamentals rather than sector or macro forces. Trading volume was elevated as investors repositioned following the earnings release, and the stock broke decisively below prior support levels, reflecting heavy selling pressure throughout the session.
What Comes Next for AIRS
Looking ahead, investors will focus on whether AIRS can stabilize same-center procedure volumes and demonstrate traction in its GLP-1-related offerings, which represented about 10% of cases in the quarter. The company has signaled targeted marketing initiatives and cost discipline as near-term priorities. Key risks include persistent weakness in consumer discretionary spending, elevated customer acquisition costs, and execution uncertainty around the turnaround. With the balance sheet refinanced, attention now shifts to whether management can deliver on its revised, more conservative outlook in the coming quarters.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with strategies that vary by timeframe, performance metrics, and traded symbols. Only the strongest performers are featured in this section, giving traders a snapshot of which approaches are currently working. Explore the page to see how AI-driven strategies are adapting to today's volatility.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AIRS's RSI Indicator ascends from oversold territory
The RSI Indicator for AIRS moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In 31 of the 35 cases the stock moved higher. This puts the odds of a move higher at 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on AIRS as a result. In 61 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for AIRS just turned positive on October 23, 2026. Looking at past instances where AIRS's MACD turned positive, the stock continued to rise in 36 of 43 cases over the following month. The odds of a continued upward trend are 84%.
Following a +20.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where AIRS advanced for three days, in 235 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 55 cases where AIRS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
AIRS broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AIRS entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.990) is normal, around the industry mean (203.977). P/E Ratio (-8.000) is within average values for comparable stocks, (20.904). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). AIRS's Dividend Yield (1.139) is considerably higher than the industry average of (0.097). P/S Ratio (0.921) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. AIRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HospitalNursingManagement
Advertisement